A Review of Animal Models of Alzheimer's Disease: a brief insight to Pharmacologic and genetic models

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Physiology and Pharmacology

• Publication date

  2016-02-10

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Synaptosomal bioenergetic defects are associated with cognitive impairment in a transgenic rat model of early Alzheimer's disease

  2017cited by this paper
• Molecular Basis of Familial and Sporadic Alzheimer's Disease.

  2016cited by this paper
• A Comprehensive Behavioral Test Battery to Assess Learning and Memory in 129S6/Tg2576 Mice

  2016cited by this paper
• Suppressor Mutations for Presenilin 1 Familial Alzheimer Disease Mutants Modulate γ-Secretase Activities*

  2015cited by this paper
• Rodent models for Alzheimer’s disease drug discovery

  2015cited by this paper
• Protocol for Three-dimensional Confocal Morphometric Analysis of Astrocytes.

  2015cited by this paper
• Amyloid-β Modulates Both AβPP and Tau Phosphorylation

  2015cited by this paper
• Naringenin improves learning and memory in an Alzheimer's disease rat model: Insights into the underlying mechanisms.

  2015cited by this paper
• Hippocampal P3-Like Auditory Event-Related Potentials are Disrupted in a Rat Model of Cholinergic Degeneration in Alzheimer's Disease: Reversal by Donepezil Treatment

  2014cited by this paper
• Abundance of Aβ5-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer’s disease

  2014cited by this paper
• Aβ38 in the Brains of Patients with Sporadic and Familial Alzheimer's Disease and Transgenic Mouse Models

  2014cited by this paper
• Uridine Prodrug Improves Memory in Tg2576 and TAPP Mice and Reduces Pathological Factors associated with Alzheimer's Disease in Related Models

  2013cited by this paper
• Modeling Alzheimer’s disease in transgenic rats

  2013cited by this paper
• Amyloid Beta1-40-Induced Astrogliosis and the Effect of Genistein Treatment in Rat: A Three-Dimensional Confocal Morphometric and Proteomic Study

  2013cited by this paper
• Modeling Alzheimer's disease with non-transgenic rat models

  2013cited by this paper
• First transgenic rat model developing progressive cortical neurofibrillary tangles.

  2012cited by this paper
• Alzheimer's disease and amyloid: culprit or coincidence?

  2012cited by this paper
• Heritability of Different Forms of Memory in the Late Onset Alzheimer's Disease Family Study

  2011cited by this paper
• Risk Profiles of Alzheimer Disease

  2011cited by this paper
• Genistein ameliorates learning and memory deficits in amyloid β(1-40) rat model of Alzheimer's disease.

  2011cited by this paper
• Inflammation and gliosis in neurological diseases--clinical implications.

  2011cited by this paper
• How many dementia cases in France and Europe? Alternative projections and scenarios 2010–2050

  2010cited by this paper
• Neuropathology of Alzheimer's disease.

  2010cited by this paper
• Prevalence of dementia disorders in the oldest-old: an autopsy study

  2010cited by this paper
• Alzheimer Disease: Update on Basic Mechanisms

  2010cited by this paper
• Mechanisms of Nitrosamine-Mediated Neurodegeneration: Potential Relevance to Sporadic Alzheimer's Disease

  2009cited by this paper
• A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition.

  2009cited by this paper
• Astrocytes: biology and pathology

  2009cited by this paper
• Molecular dissection of reactive astrogliosis and glial scar formation.

  2009cited by this paper
• Current approaches in the treatment of Alzheimer's disease.

  2008cited by this paper
• Genome-wide association studies in Alzheimer disease.

  2008cited by this paper
• The Potential for β-Structure in the Repeat Domain of Tau Protein Determines Aggregation, Synaptic Decay, Neuronal Loss, and Coassembly with Endogenous Tau in Inducible Mouse Models of Tauopathy

  2008cited by this paper
• Animal Models of Alzheimer's Disease: Therapeutic Implications

  2008cited by this paper
• Effects of familial Alzheimer's disease mutations on the folding nucleation of the amyloid beta-protein.

  2008cited by this paper
• Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

  2007cited by this paper
• Alzheimer's disease could be "type 3 diabetes".

  2006cited by this paper
• Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo

  2006cited by this paper
• Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy

  2006cited by this paper
• Behavioral phenotypes of amyloid‐based genetically modified mouse models of Alzheimer's disease

  2005cited by this paper
• Rat transgenic models with a phenotype of intracellular Aβ accumulation in hippocampus and cortex

  2004cited by this paper
• Amyloid-beta precursor protein processing in neurodegeneration.

  2004cited by this paper
• Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1.

  2004cited by this paper
• Altered mitogen-activated protein kinase signaling, tau hyperphosphorylation and mild spatial learning dysfunction in transgenic rats expressing the beta-amyloid peptide intracellularly in hippocampal and cortical neurons.

  2004cited by this paper
• Gene expression profile in streptozotocin rat model for sporadic Alzheimer’s disease

  2004cited by this paper
• The Relationship between Aβ and Memory in the Tg2576 Mouse Model of Alzheimer's Disease

  2002cited by this paper
• Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP

  2001cited by this paper
• Animal models of Alzheimer's disease and evaluation of anti-dementia drugs.

  2000cited by this paper
• Methods of Behavior Analysis in Neuroscience

  2000cited by this paper
• Clinical features of Alzheimer’s disease

  1999cited by this paper
• Hippocampal neuron and synaptophysin-positive bouton number in aging C57BL/6 mice.

  1998cited by this paper
• Cholinergic strategies for Alzheimer’s disease

  1998cited by this paper
• Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

  1996cited by this paper
• Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.

  1996cited by this paper
• β-Amyloid protein-induced Alzheimer's disease animal model

  1994cited by this paper
• High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy.

  1994cited by this paper
• Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)

  1994cited by this paper
• Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease.

  1993cited by this paper
• The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease.

  1993cited by this paper
• beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease.

  1993cited by this paper
• An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P.

  1991cited by this paper

• Therapeutic Potential of Experimental Stereotactic Hippocampal Cell Transplant in the Management of Alzheimer’s Disease

  2025cites this paper
• L-arginine mitigates choroid plexus changes in Alzheimer's disease rat model via oxidative/inflammatory burden and behavioral modulation.

  2024cites this paper
• The Effects of Probiotic Lactobacillus and Bifidobacterium Strains on Memory and Learning Behavior, Long-Term Potentiation (LTP), and Some Biochemical Parameters in β-Amyloid-Induced Rat’s Model of Alzheimer’s Disease

  2019cites this paper
• Kisspeptin-13 Improves Spatial Memory Consolidation and Retrieval against Amyloid-β Pathology

  2019cites this paper
• RODENT MODELS OF ALZHEIMER ’ S DISEASE : INTRACEREBROVENTRICULAR ADMINISTRATION OF β-AMYLOID 1-42 OLIGOMERS INTO WILD TYPE RATS AND TESTING LA 1011 DRUG CANDIDATE ON APP / PS 1 TRANSGENIC MICE Summary of Ph

  2018cites this paper
• Studies for Improving a Rat Model of Alzheimer’s Disease: Icv Administration of Well-Characterized β-Amyloid 1-42 Oligomers Induce Dysfunction in Spatial Memory

  2017cites this paper